BrainCool highlights oral mucositis study data

DrBicuspid.com staff writers
Sep 21, 2020
2018 01 09 22 19 8339 Cancer Cell 400

Swedish firm BrainCool is highlighting clinical data presented at the European Society for Medical Oncology (ESMO) virtual congress regarding the performance of its Cooral intraoral cooling device for preventing oral mucositis caused by chemotherapy.

The study, led by Karolinska University Hospital in Stockholm, included 182 patients with multiple myeloma or lymphoma who were to receive high-dose chemotherapy before undergoing a stem cell transplant. The Cooral system was as effective as ice chips in preventing severe oral mucositis, especially in patients with lymphoma (who tend to undergo longer courses of chemotherapy), the researchers found. Java Walladbegi, PhD, of the University of Gothenburg, presented the abstract at ESMO 2020.

The system has received the CE Mark in Europe, and the company is in process of obtaining 510(k) clearance in the U.S., it said.

Latest in Oral Cancer
Estela Vargas, CRDH.
What every dental practice must know about getting paid for oral cancer screenings
April 23, 2024
Bill Brodie
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
April 18, 2024
Do you have patients who can’t or simply won’t floss?
Sponsored
Do you have patients who can’t or simply won’t floss?
February 2, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
New test may be better way to detect oral cancer
March 26, 2024
Related Stories
2019 11 15 23 46 3642 Patented Stamp 400
Orofacial Pain
OncoZenge announces European patent for BupiZenge lozenge
2019 09 03 21 34 6544 Pills Supplements 400
Dental Hygiene
MediNiche releases micronutrient training video
2019 06 11 20 56 1887 Hands Shaking V3 400
Restorations
SEPA-Oral Reconstruction Foundation Regenerative Symposium to be held in October
Do you have patients who can’t or simply won’t floss?
Sponsor Content
Do you have patients who can’t or simply won’t floss?
More in Oral Cancer
What every dental practice must know about getting paid for oral cancer screenings
By Estela Vargas
There is no question that oral cancer screening is important for every practice, but what about the insurance side of the equation? Estela Vargas, CRDH, has some advice that can help on that front.
April 23, 2024
Estela Vargas, CRDH.
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
By Kevin Henry
As Oral Cancer Awareness Month continues, we take a look at a company that is using biomarkers as a way to catch oral cancer earlier and give patients a better chance of survival.
April 18, 2024
Bill Brodie
Nanoparticles to be developed to treat oral cancer
By Ava Barros
A lipid nanoparticles platform may treat oral squamous cell carcinoma by changing the genetic material of lymph nodes, according to research presented at the International Association for Dental, Oral, and Craniofacial Research.
April 1, 2024
Researcher
New test may be better way to detect oral cancer
By Ava Barros
A new test may detect a germ-fighting protein associated with oral cancer, track precancerous lesions, and determine when a biopsy is necessary. The study was recently published in Cell Reports Medicine.
March 26, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
Oral cancer detection with a stroke of a brush?
By Ava Barros
Researchers at the University of Illinois at Chicago College of Dentistry have created a diagnostic test kit that detects oral cancer early with a brush biopsy that can be done in a dental office, according to an article published by the university.
January 30, 2024
Cancer Cell
It’s not cheesy. An antimicrobial may treat oral cancer.
By Ava Barros
Researchers are conducting a clinical trial to determine whether an antimicrobial food additive found in cheese may be used to treat oral cell carcinoma, according to the University of California, Los Angeles School of Dentistry.
January 29, 2024
Bacteria Microscope
This numbing agent may kill HNC cells
By Ava Barros
The common dental numbing agent lidocaine triggers specific bitter taste receptors in the mouth that may ultimately lead to the death of head and neck cancer cells, according to a preclinical study recently published in Cell Reports.
December 5, 2023
Anesthetic Needle Vials
Young users of e-cigarettes more likely to report chronic stress
By Amerigo Allegretto
Young people who vape are more than twice as likely to report experiencing chronic stress.
October 3, 2023
Vaping Teenager
'Gates of heaven' calcium channel may drive oral cancer growth, pain
By Will Morton
New York University researchers suggest that ORAI1 calcium channel activity in oral cancer cells could be targeted to reduce the growth of oral tumors and reduce pain, according to a study that was recently published in Science Signaling.
September 12, 2023
Cell Gene Therapy Dna
MUSC researchers developing oral cancer vaccine
By Amerigo Allegretto
Researchers from the Medical University of South Carolina (MUSC) are developing a new type of personalized vaccine to prevent recurrences of oral cancer.
September 7, 2023
Researcher
Researchers awarded grant to study radiation therapy delays
By Amerigo Allegretto
Researchers from South Carolina have been awarded a $3.5 million grant to reduce delays in radiation therapy for head and neck cancers.
August 28, 2023
Radiation Therapy
Raising awareness of oral cancer through patient communication
By Misty Mattingly, RDH
With increasing rates of oral cancer, it’s time to re-examine our approach to informing patients about the risks, writes Misty Mattingly, RDH.
August 24, 2023
Misty Mattingly, RDH.
Page 1 of 115
Next Page